Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sober

Showing results (451-460 of 516) with videos related to

Pageof 52
Sort By:
CA: a Cancer Journal for Clinicians|June 16, 2004
An evidence-based staging system for cutaneous melanomaCharles M Balch, Seng-Jaw Soong, Michael B Atkins, et al.
Cancer|March 16, 2000
A new American Joint Committee on Cancer staging system for cutaneous melanomaC M Balch, A C Buzaid, M B Atkins, et al.
Journal of the American Academy of Dermatology|January 25, 2011
A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristicsSharifeh Farasat, Siegrid S Yu, Victor A Neel, et al.
Seminars in Surgical Oncology|August 19, 2003
New TNM melanoma staging system: linking biology and natural history to clinical outcomesCharles M Balch, Antonio C Buzaid, Seng-Jaw Soong, et al.
Annals of Surgery|April 1, 1981
A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent diseaseC L Day, A J Sober, A W Kopf, et al.
Journal of the American Academy of Dermatology|July 22, 2010
Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging systemBianca D Lemos, Barry E Storer, Jayasri G Iyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Final version of 2009 AJCC melanoma staging and classificationCharles M Balch, Jeffrey E Gershenwald, Seng-Jaw Soong, et al.
Annals of Surgery|January 1, 1982
Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesionsC L Day, M C Mihm, A J Sober, et al.
Journal of the American Academy of Dermatology|June 1, 1983
Predictors of late deaths among patients with clinical stage I melanoma who have not had bony or visceral metastases within the first 5 years after diagnosisC L Day, M C Mihm, A J Sober, et al.
Annals of Surgery|January 1, 1982
Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasisC L Day, M C Mihm, R A Lew, et al.
Pageof 52

Showing results (451-460 of 516) with videos related to

Sort By:
Pageof 52
CA: a Cancer Journal for Clinicians|June 16, 2004
An evidence-based staging system for cutaneous melanomaCharles M Balch, Seng-Jaw Soong, Michael B Atkins, et al.
Cancer|March 16, 2000
A new American Joint Committee on Cancer staging system for cutaneous melanomaC M Balch, A C Buzaid, M B Atkins, et al.
Journal of the American Academy of Dermatology|January 25, 2011
A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristicsSharifeh Farasat, Siegrid S Yu, Victor A Neel, et al.
Seminars in Surgical Oncology|August 19, 2003
New TNM melanoma staging system: linking biology and natural history to clinical outcomesCharles M Balch, Antonio C Buzaid, Seng-Jaw Soong, et al.
Annals of Surgery|April 1, 1981
A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent diseaseC L Day, A J Sober, A W Kopf, et al.
Journal of the American Academy of Dermatology|July 22, 2010
Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging systemBianca D Lemos, Barry E Storer, Jayasri G Iyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Final version of 2009 AJCC melanoma staging and classificationCharles M Balch, Jeffrey E Gershenwald, Seng-Jaw Soong, et al.
Annals of Surgery|January 1, 1982
Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesionsC L Day, M C Mihm, A J Sober, et al.
Journal of the American Academy of Dermatology|June 1, 1983
Predictors of late deaths among patients with clinical stage I melanoma who have not had bony or visceral metastases within the first 5 years after diagnosisC L Day, M C Mihm, A J Sober, et al.
Annals of Surgery|January 1, 1982
Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasisC L Day, M C Mihm, R A Lew, et al.
Pageof 52